siRNA, Anti-COX17, 2'-F/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT32515WQ-2F)
The product SIRGT32515WQ-2F is a type of small interfering RNA (siRNA) that targets COX17 gene and regulates the expression of gene. The siRNA interferes with the expression of COX17 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-deoxy-2ʹ-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_005694.1 |
| Related Diseases | Menkes Disease, Metal Metabolism Disorder |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT33515WQ-2MOE | COX17 | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT34515WQ-LNA | COX17 | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT31515WQ-RB | COX17 | Human | Ribo-modified | ||
| SIRGT32515WQ-BB | COX17 | Human | Backbone-modified |
